This synthetic antioxidant compound reduces inflammation and UV damage to skin cells that can cause wrinkles and hyperpigmentation. (It's only found in Prevage products by Elizabeth Arden at a 0.5 percent concentration and in Prevage MD, available in dermatologists' offices, at a 1 percent concentration.) Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe. It is approved by the European Medicines Agency (EMA) for use in Leber's hereditary optic neuropathy (LHON) and was designated an orphan drug in 2007. Chemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).
Subscribe to our e-mails
Receive the latest news in skin care routines and innovations delivered to your Inbox.